Study design: Prospective health economic evaluation
1398-9995/asset/olbannerleft.gif?v=1&s=2207070238298c1b0c4b1e73fa97140fa65e5f81)
1398-9995/asset/olbannerright.gif?v=1&s=c902da976bf6db24fc36ec0480207615a3d14921)
You have full text access to this OnlineOpen article
Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma
Article first published online: 12 NOV 2008
DOI: 10.1111/j.1398-9995.2008.01743.x
© 2008 The Authors. Journal compilation © 2008 Blackwell Munksgaard
Additional Information
How to Cite
Nasser, S., Vestenbæk, U., Beriot-Mathiot, A. and Poulsen, P. B. (2008), Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma. Allergy, 63: 1624–1629. doi: 10.1111/j.1398-9995.2008.01743.x
Publication History
- Issue published online: 12 NOV 2008
- Article first published online: 12 NOV 2008
- Accepted for publication 6 March 2008
References
- 1, . The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006;368:780–793.
- 2, , , . Uncontrolled asthma: a review of prevalence, disease burden and option for treatment. Respir Med 2006;100:1139–1151.
- 3, , , , , et al. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol 2004;113:86–93.
- 4, , , Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:147–334.
- 5. Allergic rhinitis and asthma: are they manifestations of one syndrome? Clin Exp Allergy 2006;36:1–4.
- 6, , , . Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004;34:520–526.
- 7Asthma UK. Where do we stand? Asthma in the UK today. http://www.asthma.org.uk/document.rm?id=92.
- 8, , , . Impact of asthma on self-reported health status and quality of life: a population based study of Australians aged 18–64. Thorax 2005;60:735–739.
- 9, , , , , et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008;38:19–42.
- 10, , , , , et al. Long-term clinical efficacy of grass-pollen allergen specific immunotherapy. N Engl J Med 1999;34:468–475.
- 11, , , . Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002;109:57–62.
- 12, , , , , et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablet for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118:434–440.
- 13, , , , , et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with selected medical conditions in the United States from an employer perspective. Curr Med Res Opin 2006;22:1203–1210.
- 14, , , , . Methods for the economic evaluation of health care programmes, 3rd edn. Oxford: Oxford Medical Publications, Oxford University Press, 2005.
- 15EFA (European Federation of Allergy and Airway Diseases Patients Association). Results of the patient voice allergy survey. Impact of allergic rhinitis in Europe. Summary Report (2005) ( http://www.efanet.org/ ).
- 16, . Unit Costs of Health and Social Care 2004, Personal Social Services Research Unit, University of Kent, Canterbury. http://www.pssru.ac.uk/pdf/uc2004/uc2004.pdf .
- 17Department of Health. NHS reference costs 2004. http://www.dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/DH_4105545?Idcservice-GET_FILE&dID=19536&Reudition-Web.
- 18, , , , , et al. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 2008;121:512–518.
- 19, . Does the effect of allergen-specific immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988;43:523–529.
- 20, , . Long-lasting effect of sublingual allergen specific immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003;33:468–475.
- 21, , , , , . Usefulness of allergen specific immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265–269.
- 22NHS. National Institute of Clinical Excellence. Guide to the Methods of Technology Appraisal. April, 2004. http://www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf
- 23, . National Institute of Clinical Excellence (NICE): is economic appraisal working. Pharmacoeconomics 2002;20:95–105.
- 24, . National Institute for Clinical Excellence and its value judgements. BMJ 2004;329:224–227.
- 25, , , , , et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. J Allergy Clin Immunol 2001;108:39–46.
- 26, , , , , et al. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 2006;61:531–536.